Docking Protein 6 (DOK6) (Middle Region) Peptide
-
- Target See all DOK6 products
- DOK6 (Docking Protein 6 (DOK6))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- IYSLQGHGFG SSKMSRAQTF PSYAPEQSEE AQQPLSRSSS YGFSYSSSLI
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-DOK6 Antibody(ARP55502_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- DOK6 (Docking Protein 6 (DOK6))
- Background
-
DOK6 is a member of the DOK (see DOK1, MIM 602919) family of intracellular adaptors that play a role in the RET (MIM 164761) signaling cascade (Crowder et al., 2004 [PubMed 15286081]).
Alias Symbols: DOK5L, HsT3226, MGC20785
Protein Interaction Partner: RET,RET
Protein Size: 331 - Molecular Weight
- 38 kDa
- Gene ID
- 220164
- NCBI Accession
- NM_152721, NP_689934
- UniProt
- Q6PKX4
-